Hanxin Pharmaceutical Technology Co., Ltd. specializes in the R&D, production, and sales of animal extracts, biological fermentation raw materials, and drug products, and provides customers with whole services during drug development life cycle covering preclinical research, pilot-scale development, validation and registration batches manufacturing, and commercial-scale manufacturing, along with supporting production bases, which can simultaneously meet filing requirements in China and the United States.
Hanxin has enabled more than 100 collaborations of innovative projects to help partners improving their research and development efficiency.
Submitted DMF for Hyaluronidase and Heparin Sodium
Since its establishment in early 2017, Hanxin has been recognized as "Jiangsu Provincial Technology-Advanced Service Enterprise", "Nanjing Recombinant Drug Engineering Technology Research Center", and obtained national-level intellectual property management system certification and CNAS laboratory accreditation certificate. Hanxin has also been recognized as "National High-tech Enterprise" in 2021.
Establishment of Biological R&D Department
Submitted DMF for Insulin Aspart and Passed FDA Inspection
Add:Building C5, No.9 Weidi Road, Xianlin Street, Qixia District, Nanjing City, Jiangsu Province, China
|